Malaria drug fails to prevent COVID-19 in a rigorous study
Por um escritor misterioso
Descrição
A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.
FDA authorizes emergency use of unapproved drugs to treat coronavirus - The Washington Post
Very weak evidence base for antiretrovirals for treatment and prevention of COVID-19, say senior HIV doctors
Desperation rather than information driving COVID-19 decisions
Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study - The Lancet Infectious Diseases
Malaria drug touted by Trump fails to prevent COVID-19 in high profile study
Malaria drugs fail to help in coronavirus studies - Los Angeles Times
US hospitals slash use of drug championed by Donald Trump as coronavirus treatment
Severe Covid-19
Covid-19: Study concludes hydroxychloroquine could do more harm than good
The 'very, very bad look' of remdesivir, the first FDA-approved COVID-19 drug, Science
/cloudfront-us-east-1.images.arcpublishing.com/gray/2XA2XVX57NMBBIQJ5DZB3ETXFY.jpg)
Malaria drug fails to prevent COVID-19 in a rigorous study
Study finds hydroxychloroquine, drug touted by Trump, is not useful and may be harmful for COVID-19 patients - CBS News
Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis
Questions raised over hydroxychloroquine study which caused WHO to halt trials for Covid-19, Medical research
de
por adulto (o preço varia de acordo com o tamanho do grupo)
